1 | Positivea | Butyryl-fentanyl, oxycodone, etizolam, diphenhydramine, THC | CYP3A, CYP2D6 | Lalovic et al. (2004); Niwa et al. (2005); Kanamori et al. (2019) |
2 | Positive | Oxycodone, fluoxetine, pseudoephedrine | CYP3A, CYP2D6 | Lalovic et al. (2004); LLerena et al. (2004) |
3 | 0.04 | Etizolam, 5-MeO-AMT | CYP3A | Niwa et al. (2005) |
4 | Positive | Morphine, codeine | UGT2B7, CYP3A, CYP2D6 | Crews et al. (2014) |
5 | 0.35 | Oxycodone, tramadol, topiramate, diphenhydramine, zolpidem | CYP3A, CYP2D6 | Pichard et al. (1995); Miotto et al. (2017); Yamamoto et al. (2017) |
6 | 5.3 | Citalopram | CYP3A, CYP2C19, CYP2D6 | von Moltke et al. (2001) |
7 | 3.5 | Furanyl-fentanyl | NA | NA |
8 | 2.5 | Temazepam, olanzapine, sertraline, clonazepam | CYP3A, CYP2C9, CYP2C19, CYP2D6, UGT2B7 | Kobayashi et al. (1999); Urichuk et al. (2008); Tóth et al. (2016) |
9 | 0.42 | 3,4-Dimethoxy-N-methylamphetamine | NA | NA |
10 | 6.7 | Etizolam, nordiazepam, mirtazapine | CYP3A, CYP2D6, CYP1A2 | Ono et al. (1996); Störmer et al. (2000); Niwa et al. (2005) |
11 | 12 | 2,4,5-Trimethoxyamphetamine | CYP2D6 | Ewald and Maurer (2008) |
12 | 0.62 | Oxycodone | CYP3A, CYP2D6 | Lalovic et al. (2004) |
13 | 1.9 | Oxycodone, fentanyl, cocaine | CYP3A, CYP2D6, esterases | Kamendulis et al. (1996); Guitton et al. (1997); Kanamori et al. (2019) |
14 | Positive | —b | — | — |
15 | Positive | U-47700 | NA | NA |